BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26494212)

  • 1. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
    Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
    Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
    Tremosini S; Forner A; Boix L; Vilana R; Bianchi L; Reig M; Rimola J; Rodríguez-Lope C; Ayuso C; Solé M; Bruix J
    Gut; 2012 Oct; 61(10):1481-7. PubMed ID: 22287594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity.
    Moudi B; Heidari Z; Mahmoudzadeh-Sagheb H; Alavian SM; Lankarani KB; Farrokh P; Randel Nyengaard J
    Eur J Histochem; 2018 Jan; 62(1):2859. PubMed ID: 29569872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
    Fu L; Wu S; Yao T; Chen Q; Xie Y; Ying S; Chen Z; Xiao B; Hu Y
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28493512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Kwon SH; Jeong SW; Jang JY; Lee JE; Lee SH; Kim SG; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY
    Clin Mol Hepatol; 2012 Sep; 18(3):287-94. PubMed ID: 23091809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma.
    Kang GH; Lee BS; Lee ES; Kim SH; Lee HY; Kang DY
    Gut Liver; 2014 Jan; 8(1):79-87. PubMed ID: 24516705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules.
    Lim SO; Park SG; Yoo JH; Park YM; Kim HJ; Jang KT; Cho JW; Yoo BC; Jung GH; Park CK
    World J Gastroenterol; 2005 Apr; 11(14):2072-9. PubMed ID: 15810071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Significance of Insulin Receptor Substrate 1 in Human Hepatocellular Carcinoma.
    Gao C; Zhang H; Zhang WS; Fang L
    Dis Markers; 2020; 2020():7174062. PubMed ID: 32695243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J
    Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
    Harada K; Shiota G; Kawasaki H
    Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients.
    Attallah AM; El-Far M; Abdelrazek MA; Omran MM; Attallah AA; Elkhouly AA; Elkenawy HM; Farid K
    Br J Biomed Sci; 2017 Oct; 74(4):170-175. PubMed ID: 28705056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.
    Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D
    Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of HSP70 and HSP27 in hepatocellular carcinoma.
    Joo M; Chi JG; Lee H
    J Korean Med Sci; 2005 Oct; 20(5):829-34. PubMed ID: 16224158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis.
    Tsuzura H; Genda T; Sato S; Murata A; Kanemitsu Y; Narita Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Ichida T
    Int J Mol Sci; 2014 Apr; 15(4):6556-68. PubMed ID: 24747592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
    Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases.
    Chen GG; Lai PB; Chak EC; Xu H; Lee KM; Lau WY
    Cancer Lett; 2001 Oct; 172(1):75-82. PubMed ID: 11595132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
    Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors.
    Reis H; Pütter C; Megger DA; Bracht T; Weber F; Hoffmann AC; Bertram S; Wohlschläger J; Hagemann S; Eisenacher M; Scherag A; Schlaak JF; Canbay A; Meyer HE; Sitek B; Baba HA
    Biochim Biophys Acta; 2015 Jun; 1854(6):641-50. PubMed ID: 25448011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.